Tobacco use and baseball

Source: www.quitsmokingforyou.com Like cigarettes, smokeless tobacco (snuff and chewing tobacco), cause mouth cancer, gum disease, and heart disease. Yet many think that chewing tobacco is safe or less so than smoking. This is not true! In 1986, the Surgeon normal closed that the use of smokeless tobacco “is not a safe substitute for smoking cigarettes. It can cause cancer and a whole of noncancerous conditions and can lead to nicotine addiction and dependence.” Since 1991, the National Cancer institute (Nci) has officially recommended that the group avoid and desist the use of all tobacco products, including smokeless tobacco. Nci also recognizes that nitrosamines, found in tobacco products, are not safe at any level. Chewing tobacco and baseball have a long tight affiliation, rooted in the cultural confidence among players and fans that baseball players chew tobacco and it is just part of the grand old game. This mystique is slowing changing with campaigns by ballplayers who have had or have seen friends with mouth cancer caused by chewing tobacco use. Jeff Bagwell Jeff Bagwell, retired first baseman with the Houston Astros and Joe Garagiola, a previous baseball player and commentator, campaign against tobacco use among children and addicted adults. In 1993, when Bagwell was 25-years-old, his dentist discovered leukoplakia, a whitish pre-cancerous sore in his mouth where he continually located chewing tobacco. About 5% of leukoplakias institute into cancer. Fortunately this did not happen to Jeff Bagwell due to the early detection by his dentist. Rick Bender, The Man Without [...]

2012-06-04T20:47:24-07:00June, 2012|Oral Cancer News|
Read More

If You Fail to Look

Source: The American Academy of Oral Systemic Health Newsletter Author: Cris Duval Detecting oral cancer in its earliest stages saves lives, eases suffering, reduces morbidity, and ameliorates post-surgery recovery. Remember when you took driver’s education in high school?  I do! When I grew up, driver’s education students in Washington State were required to watch “shock” highway-safety films. These videos, depicting the aftermath of drivers’ actions, showed actual accident scenes, complete with audio recordings of victims’ screams and color close-ups of mangled bodies.  My bet is that, if you have ever watched one of these videos, you have never forgotten it. For me, when I saw these videos, I thought about my family and my friends.  I know that I have a family that loves and cares about me, and thus, I owe it to them to avoid doing something stupid behind-the-wheel.  I never want one of my loved ones to have to go through the pain of seeing me hurt. This means to me that my driver’s license is more than just a “key” to get behind the wheel.  Rather, as a website for traffic safety in Texas states, a driver’s license signifies that the driver possesses the “essential knowledge, skills, and experience to perform reduced risk practices in [a] total traffic environment.”  In other words, the driver is accountable to himself and other drivers. My response to these driver’s education videos is akin to my reaction to videos that I watched at the Pacific Northwest Head, Neck & Thyroid Cancer [...]

2012-06-01T09:35:08-07:00June, 2012|Oral Cancer News|
Read More

Penn study finds delayed side effects of head and neck cancer treatments go unreported

Source: Eurekalert.org Results reinforce need for improved 'survivorship care' to encourage patients to seek help for their symptoms CHICAGO – New data from an Internet-based study show that patients with head and neck cancers (HNC) may be at risk for significant late effects after their treatment, but they're unlikely to discuss these and other survivorship care issues with their doctors. The findings, from researchers at the Perelman School of Medicine at the University of Pennsylvania, will be presented Monday, June 4, at the 2012 American Society of Clinical Oncology (ASCO) meeting in Chicago. The research team says the study reinforces the need to improve survivorship care for patients as they complete their active treatment, better educate patients about late effects they may experience, and encourage them to report these problems to their healthcare providers so they can be addressed. Data from nearly 4,000 cancer survivors were gathered between April 2010 and October 2011 via patients who completed LIVESTRONG Care Plans via OncoLink, Penn Medicine's online cancer resource. Approximately four percent of those patients had been treated for a primary head or neck cancer. Of those, nearly 88 percent reported having undergone radiation, 73 percent surgery, and 67 percent chemotherapy. Many patients reported late effects such as difficulty swallowing/speaking (83 percent), decreased saliva production (88 percent), thyroid problems (33 percent), decreased neck mobility (60 percent), concerns regarding cognitive function (53 percent), or vision deficits. However, since results show that patients only discuss the survivorship care plans they created on the site [...]

2012-05-31T12:09:42-07:00May, 2012|Oral Cancer News|
Read More

The UK’s first robotic mouth cancer operation

Source: www.privatehealth.co.uk Author: staff Pioneering surgery which allows doctors to remove cancer in the mouth using a minimally invasive technique is now available at the Wellington Hospital. Traditionally, the only way to remove Squamous Cell Carcinoma – cancer of the oropharynx which encompasses the tonsils and base of the tongue – has been to split the jaw, take out the cancer and repair the neck with tissue from the forearm. This 10-hour procedure requires two surgical teams and often has complications. Patients are in hospital for at least three weeks and need months of rehabilitation to help them swallow and speak again. Because the treatment is so invasive, many doctors try to avoid it using chemotherapy and radiotherapy instead. However, surgery is often the best chance of a cure. The new one-hour technique called Transoral Robotic Surgery allows the cancer to be removed without splitting the jaw or taking tissue from other parts of the body. Instead, the tonsils are accessed through the mouth using a specially designed robotic machine. Developed in the US in 2009 and now approved by the American Food and Drug Administration and licensed for use in the UK, it uses the Da Vinci robot to access this difficult to reach area. It gives the surgeon greater precision, dexterity and accuracy while carrying out the procedure and the patient has no stitches. Infection rates are reduced which speeds up recovery rates, patients are in hospital for just a week and are able to swallow normally soon afterwards [...]

2012-05-30T13:56:28-07:00May, 2012|Oral Cancer News|
Read More

Advaxis recruiting for HPV+ head and neck cancer trial

Source: www.cancertreatment.net Author: Ross Bonander Advaxis is announcing the enrollment of patients into the REALISTIC Phase I/II trial sponsored by Cancer Research UK to evaluate ADXS-HPV for the treatment of HPV-positive head and neck cancer. HPV has been linked to as many as seventy percent of all head and neck cancers. ADXS-HPV is a next-generation immunotherapy that acts as a therapeutic vaccine and is being tested in trials against HPV-associated diseases, including cervical cancers. Cancer Research UK assumes all patient costs. Advaxis seeks to recruit 45 patients. The REALISTIC trial is being carried out at the Aintree Hospital at the University of Liverpool, the Royal Marsden Hospital at the University of London, and the Cardiff Hospital at the University of Wales. Qualified patients will have already received treatment for head and neck cancer, either surgery, radiotherapy, chemotherapy, or a combination of treatments. Head and neck cancers account for roughly three percent of all cancers in the US, according to the American Cancer Society. They are more commonly diagnosed in men than women, and while they are traditionally linked to smoking and to alcohol consumption, HPV-related oropharyngeal cancers are on the rise among white males under 50 years of age. "We are pleased to be working with an internationally-renowned oncology group to further expand the ADXS-HPV clinical development program to another HPV-associated tumor type," said Advaxis Chairman & CEO Thomas A. Moore. "Through this collaboration, we hope that our proprietary technology will be able to offer a new treatment option to [...]

2012-05-24T14:21:07-07:00May, 2012|Oral Cancer News|
Read More

Suicide Rates Among Oral Cancer Patients on the Rise

Source: Dr.Bicuspid.com May 23, 2012 -- Suicide rates among patients with oral cavity and oropharyngeal (OC/OP) cancer have increased significantly over the past three decades, particularly among male patients during the first year after diagnosis. As many as half of patients with head and neck cancer suffer from depression, among the highest of all oncology patients (Clinical Advances in Hematology & Oncology, June 2009 Vol. 7:6, pp. 397-403). However, despite documented high rates of depression and suicide among patients with head and neck cancer, studies examining suicide and other noncancer-related deaths in patients with OC/OP have not been published. Brian Hill, executive director of the Oral Cancer Foundation, survived stage 4 bilateral cervical lymph node metastases from oropharyngeal cancer. This gap prompted researchers from the New York Eye and Ear Infirmary, New York Medical College, and Peking University to analyze 32,487 patients with OC/OP cancer using the Surveillance, Epidemiology, and End Results cancer registry data for 1980-1984, 1990-1994, 2000-2003, and 2004-2007 (Archives of Otolaryngology-Head & Neck Surgery, January 2012, Vol. 138:1, pp. 25-32). They found that from 1980-1984 to 2004-2007, deaths from suicide increased by 406.2% (p = .01), while cardiovascular disease-related and pneumonia-related deaths decreased by 45.9% (p < .001) and 42.9% (p = .009), respectively. Risk factors for mortality included age (55-64), marital status, advanced tumor stage, and tumor location. The researchers also calculated standardized mortality ratios (SMRs) for suicide, cardiovascular disease, and pneumonia and compared them with patient demographic and clinical characteristics. The risk of death from [...]

2012-05-24T10:21:11-07:00May, 2012|OCF In The News, Oral Cancer News|
Read More

The Dangers of Self Diagnosis via the Internet

Source: ABC News (Australian Broadcasting Corporation) Do you have a rash and a sore throat? A high fever? A splitting headache? Forget spending time and money on seeing a doctor - there is a plethora of internet sites that will help you diagnose your own illness for free. Simply answer a series of questions about your age, body measurements and symptoms and the internet will do the rest. The Australian Medical Association says it's seriously concerned with the increasing number of WA residents who are doing just that. Last year, a study found nearly 80 per cent of Australians get health information off the net, with almost half of those doing so to diagnose a medical condition. The AMA's Doctor Richard Chong says those statistics seem to reflect local trends in WA. "Every single day I see patients that have come to me after checking their symptoms on the internet," he said. "I accept that it's a part of life now due to the sheer number of people who're more familiar with the internet. "To be honest, most people who do it aren't harmed." "They rush in thinking they have something that's going to kill them when they're actually fine." Dr Chong is, however, concerned about people who don't go to their GP because their research has reassured them that nothing's wrong. "At least with the first group of people, we get to discuss their symptoms because they always come in," he said. "The people that don't are the ones [...]

2012-05-23T09:27:03-07:00May, 2012|Oral Cancer News|
Read More

Vitamin B veggies cut risk of mouth cancer

Source: www.dentistry.co.uk Author: staff Women who consume high volumes of folic acid found in vitamin B from vegetables and some fruits are less likely to suffer from mouth cancer. A sample of 87,000 nurses were followed for 30 years from 1976 by researchers from the Columbia University Medical Centre and Harvard School of Public Health. Women who drank a high volume of alcohol and had low folic acid intake were three times more likely to develop mouth cancer than those who drank high volumes of alcohol but had high volumes of folic acid in their diet. Alcohol is one of the major risk factors for mouth cancer and those who drink to excess are four times more likely to be diagnosed. This is the first time that folic acid intake has been shown to affect the risk of the disease. Alcohol leads to a reduction in folic acid metabolism by creating acetaldehyde which leads to a reduction of folic acid in the body. Chief executive of the British Dental Health Foundation, Dr Nigel Carter, said: 'Rates of mouth cancer in women have been increasing for many years as a result of changed social habits with more women smoking and drinking. 'This new research could offer a method to reduce this by looking at the folic acid intake and increasing fruit and vegetables containing folic acid in the diet. “In the past studies have tended to focus on males, as they are twice as likely to suffer from the disease. While [...]

2012-05-20T17:52:11-07:00May, 2012|Oral Cancer News|
Read More

Oral sex may cause more oral cancer than smoking in men, researchers say

Source: www.bloomberg.com Author: Robert Langreth A virus spread by oral sex may cause more cases of throat cancer in men than smoking, a finding that spurred calls for a new large-scale test of a drug used against the infection. Researchers examined 271 throat-tumor samples collected over 20 years ending in 2004 and found that the percentage of oral cancer linked to the human papillomavirus, or HPV, surged to 72 percent from about 16 percent, according to a report released yesterday in the Journal of Clinical Oncology. By 2020, the virus-linked throat tumors -- which mostly affected men -- will become more common than HPV-caused cervical cancer, the report found. HPV is known for infecting genitals. The finding that it can spread to the throat and cause cancer may increase pressure on Merck & Co., the second-largest U.S. drugmaker, to conduct large-scale trials to see if its vaccine Gardasil, which wards off cervical cancer in women, also prevents HPV throat infections. “The burden of cancer caused by HPV is going to shift from women to men in this decade,” Maura Gillison, an oncologist at Ohio State University and study senior author, said in a telephone interview. “What we believe is happening is that the number of sexual partners and exposure to HPV has risen over that same time period.” Gillison said she worked with researchers at Whitehouse Station, New Jersey-based Merck several years ago to design a study in men. After Merck acquired Schering-Plough Corp. in 2009, though, the trial “was canceled,” [...]

2012-05-20T20:54:05-07:00May, 2012|Oral Cancer News|
Read More
© - The Oral Cancer Foundation - Head & Neck Cancer IRS 501(c)3 Charity - 3419 Via Lido #205, Newport Beach, CA 92663 | Disclaimer / Privacy Policy
Go to Top